Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Thoracic 2Sarcoma 2Gastrointestinal 2Plasma cell 1Genitourinary 1CNS 1

Conditions

Sarcoma 1Liposarcoma 1Leiomyosarcoma 1

Interventions

Specimen Handling 14Magnetic Resonance Spectroscopy 14Doxorubicin 12Cyclophosphamide 11Temozolomide 9Biopsy 9Radiation 8atezolizumab 7Radiotherapy 7X-Rays 6Vincristine 6Nivolumab 6Etoposide 6Bevacizumab 6pembrolizumab 5liposomal doxorubicin 5fludarabine 5cabozantinib 5Sirolimus 5Phantoms, Imaging 5Irinotecan 5Immunoglobulin G 5Ifosfamide 5Disulfides 5Nuclear Medicine Department, Hospital 4temsirolimus 3palbociclib 3olaparib 3fludarabine phosphate 3Surgical Procedures, Operative 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoadjuvant Therapy × Sarcoma × 30 days × Clear all
NCT07612098 2026-05-28

SPARE-04

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
274 enrolled
Sarcoma

Sarcoma

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
250 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡